ArticleEJHaem2024

A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocol.

Neil D Palmisiano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.